Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Buy
41
+7
+21% +$848 ﹤0.01% 850
2026
Q1
$5K Sell
34
-4
-11% -$615 ﹤0.01% 671
2025
Q4
$6K Hold
38
﹤0.01% 620
2025
Q3
$5K Buy
38
+2
+6% +$245 ﹤0.01% 648
2025
Q2
$3K Buy
+36
New +$2.75K ﹤0.01% 726

Other funds holding INSM

Avion Wealth's INSM Position: Q2 2026 in Review

Avion Wealth increased its Insmed (INSM) stake by 21% in Q2 2026, buying an estimated $848 and bringing the position to 41 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #850.

Avion Wealth first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $6K in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Avion Wealth held 41 shares of Insmed worth $4K as of Q2 2026.
  • Avion Wealth bought 7 Insmed shares in Q2 2026, an estimated $848.
  • Insmed made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #850 holding.
  • Avion Wealth first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Avion Wealth's Insmed position peaked at $6K in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.